38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial results for the three months ended June 30th , 2021 and issued a business update.
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 18 companies set new 52-week highs.
Wells Fargo Maintains Overweight on Synopsys, Raises Price Target to $340
Wells Fargo analyst Gary Mobley maintains Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $325 to $340.
Rosenblatt Maintains Buy on Synopsys, Raises Price Target to $314
Rosenblatt analyst John McPeake maintains Synopsys (NASDAQ:SNPS) with a Buy and raises the price target from $313 to $314.
Keybanc Maintains Overweight on Synopsys, Raises Price Target to $347
Keybanc analyst Jason Celino maintains Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $320 to $347.
Synopsys: Q3 Earnings Insights
Shares of Synopsys (NASDAQ:SNPS) rose in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share rose 4.02% year over year to $1.81, which beat the estimate of $1.78.
Synopsys Q3 EPS $1.81 Beats $1.78 Estimate, Sales $1.06B Beat $1.05B Estimate
Synopsys (NASDAQ:SNPS) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.78 by 1.69 percent. This is a 4.02 percent increase over earnings of $1.74 per share from the same